Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Gepubliceerd in:
Fundamentele aspecten van kanker hoofdstuk lezen eerste hoofdstuk lezen

2020 | OriginalPaper | Hoofdstuk

3. Epidemiologie van kanker

Auteurs : Prof. dr. V. E. P. P. Lemmens, Prof. dr. A. M. May

Gepubliceerd in: Leerboek oncologie

Uitgeverij: Bohn Stafleu van Loghum

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Samenvatting

Kanker heeft een toenemende impact op de bevolking. Sinds 2008 is kanker doodsoorzaak nummer één in Nederland (CBS: www.​cbs.​nl). Daarnaast groeit het aantal mensen dat ieder jaar de diagnose kanker krijgt nog steeds, en neemt het aantal mensen dat nog in leven is en ooit de diagnose kanker kreeg ook gestaag toe (Kanker 2020). Vooral door de toenemende vergrijzing zal de impact van kanker de komende decennia alleen maar groter worden. Er zijn echter ook positieve ontwikkelingen. Zo neemt het aantal patiënten dat de ziekte overleeft fors toe, vooral dankzij vroegere opsporing en effectievere behandelmethoden. Er is de laatste jaren ook veel meer aandacht voor de kwaliteit van de zorg en transparantie daarvan. De patiënt staat steeds vaker centraal, wat zich uit in een grotere belangstelling vanuit de kliniek voor het meten van de kwaliteit van leven en Patient Reported Outcome Measures (PROM’s). Zonder gedegen kennis over de meest wezenlijke trends in het vóórkomen van kanker en de overleving na kanker is het echter onmogelijk om beleidskeuzes en klinische ontwikkelingen adequaat te evalueren en de juiste waarde ervan te schatten. Dit hoofdstuk gaat aan de hand van een aantal voorbeelden in op de belangrijkste trends in het vóórkomen (incidentie) van en de overleving en sterfte na kanker, en zet Nederland daar waar relevant in een internationaal perspectief.
vorige hoofdstuk Klinisch-genetische aspecten van kanker
volgende hoofdstuk Beeldvorming
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
Aarts MJ, Aerts JG, Van den Borne BE, Biesma B, Lemmens VE, Kloover JS. Comorbidity in patients with small-cell lung cancer: trends and prognostic impact. Clin Lung Cancer. 2015;16(4):282–91.CrossRefPubMed
Alexander S, Lemmens VE, Houterman S, Nollen L, Roumen R, Slooter GD. Gallbladder cancer, a vanishing disease? Cancer causes & control: CCC. 2012;23(10):1705–9.CrossRefPubMed
Anderson KN, Schwab RB, Martinez ME. Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat. 2014;144(1):1–10.PubMedPubMedCentralCrossRef
Andres A. Cancer incidence after immunosuppressive treatment following kidney transplantation. Critical reviews in oncology/hematology. 2005;56(1):71–85.CrossRefPubMed
Bokhorst LP, Bangma CH, Van Leenders GJ, Lous JJ, Moss SM, Schroder FH, et al. Prostate-specific antigen-based prostate cancer screening: reduction of prostate cancer mortality after correction for nonattendance and contamination in the Rotterdam section of the European randomized study of screening for prostate cancer. Eur Urol. 2014;65(2):329–36.CrossRefPubMed
Cremers RG, Karim-Kos HE, Houterman S, Verhoeven RH, Schroder FH, Van der Kwast TH, et al. Prostate cancer: trends in incidence, survival and mortality in the Netherlands, 1989–2006. Eur J Cancer. 2010;46(11):2077–87.CrossRefPubMed
Cuneo KC, Dash RC, Wilke LG, Horton JK, Koontz BF. Risk of invasive breast cancer and ductal carcinoma in situ in women with atypical papillary lesions of the breast. Breast J. 2012;18(5):475–8.CrossRefPubMed
Dassen AE, Lemmens VE, Van de Poll-Franse LV, Creemers GJ, Brenninkmeijer SJ, Lips DJ, et al. Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer. 2010;46(6):1101–10.CrossRefPubMed
De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE–5-a population-based study. Lancet Oncol. 2014;15(1):23–34.CrossRefPubMed
De Melker H, Kenter G, Van Rossum T, Conyn-van Spaendonck M. Developments in HPV vaccination. Ned Tijdschr Geneeskd. 2012;156(47):A5410.PubMed
De Vries E, Trakatelli M, Kalabalikis D, Ferrandiz L, Ruiz-de-Casas A, Moreno-Ramirez D, et al. Known and potential new risk factors for skin cancer in European populations: a multicentre case-control study. Br J Dermatol. 2012a;167(Suppl 2):1–13.CrossRefPubMed
De Vries E, Micallef R, Brewster DH, Gibbs JH, Flohil SC, Saksela O, et al. Population-based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regions. Arch Dermatol. 2012b;148(3):347–54.CrossRefPubMed
Dikken JL, Lemmens VE, Wouters MW, Wijnhoven BP, Siersema PD, Nieuwenhuijzen GA, et al. Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. Eur J Cancer. 2012;48(11):1624–32.CrossRefPubMed
Doll R, Hill AB. Lung cancer and other causes of death in relation to smoking; a second report on the mortality of British doctors. Br Med J. 1956;2(5001):1071–81.PubMedPubMedCentralCrossRef
Eijsink JJ, Van der Zee AG. New strategies for screening cervical cancer; response to the Dutch college of general practitioner’s practice guideline ‘prevention and early diagnosis of cervical cancer’. Ned Tijdschr Geneeskd. 2009;153:A628.PubMed
Elferink MA, Van Steenbergen LN, Krijnen P, Lemmens VE, Rutten HJ, Marijnen CA, et al. Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989–2006. Eur J Cancer. 2010;46(8):1421–9.CrossRefPubMed
Elferink MA, Van der Vlugt M, Meijer GA, Lemmens VE, Dekker E. Colorectaal carcinoom in Nederland: situatie vóór en na invoering van het landelijke bevolkingsonderzoek. Ned Tijdschr Geneeskd. 2014;158:A7699.PubMed
Gramolelli S, Schulz TF. The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma. J Pathol. 2015;235(2):368–80.CrossRefPubMed
Groopman JD, Johnson D, Kensler TW. Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer risk. Cancer biomarkers: section A of Disease markers. 2005;1(1):5–14.CrossRefPubMed
Haedicke J, Iftner T. Human papillomaviruses and cancer. Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology. 2013;108(3):397–402.CrossRef
Hayes JH, Barry MJ. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. JAMA. 2014;311(11):1143–9.CrossRefPubMed
Janssen-Heijnen ML, Houterman S, Lemmens VE, Louwman MW, Maas HA, Coebergh JW. Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Critical reviews in oncology/hematology. 2005;55(3):231–40.CrossRefPubMed
Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013;105(3):175–201.PubMedPubMedCentralCrossRef
Kanker in Nederland tot. Trends en prognoses. Amsterdam: KWF Kankerbestrijding; 2020. p. 2011.
Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2014;23(5):700–13.CrossRef
Lanting CI, De Vroome EM, Elias SG, Van den Brandt PA, Van Leeuwen FE, Kampman E, et al. Contribution of lifestyle factors to cancer: secondary analysis of Dutch data over 2010 and a projection for 2020. Ned Tijdschr Geneeskd. 2014;159:A8085.PubMed
Maskarinec G, Noh JJ. The effect of migration on cancer incidence among Japanese in Hawaii. Ethn Dis. 2004;14(3):431–9.PubMed
Nelsen EM, Kirihara Y, Takahashi N, Shi Q, Lewis JT, Namasivayam V, et al. Distribution of body fat and its influence on esophageal inflammation and dysplasia in patients with Barrett’s esophagus. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association. 2012;10(7):728–34; quiz e61–2.
Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2010;42(Suppl 3):S206–14.CrossRef
Oh JK, Weiderpass E. Infection and cancer: global distribution and burden of diseases. Ann Glob Health. 2014;80(5):384–92.CrossRefPubMed
Parkin DM, Boyd L, Walker LC. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer. 2011;105(Suppl 2):S77–81.PubMedPubMedCentralCrossRef
Peto J. Cancer epidemiology in the last century and the next decade. Nature. 2001;411(6835):390–5.CrossRefPubMed
Potter JD. Nutritional epidemiology – thereʼs life in the old dog yet! Cancer Epidemiol Biomarkers Prev. 2015;24(2):323–30.CrossRefPubMed
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–78.PubMedCrossRef
Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association. 2007;5(12):1413–7, 7 e1–2.
Roura E, Castellsague X, Pawlita M, Travier N, Waterboer T, Margall N, et al. Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort. International Journal of Cancer Journal International du Cancer. 2014;135(2):453–66.CrossRefPubMed
Scoccianti C, Lauby-Secretan B, Bello PY, Chajes V, Romieu I. Female breast cancer and alcohol consumption: a review of the literature. Am J Prev Med. 2014;46(3 Suppl 1):S16–25.CrossRefPubMed
Sikkema M, De Jonge PJ, Steyerberg EW, Kuipers EJ. Risk of esophageal adenocarcinoma and mortality in patients with Barrett’s esophagus: a systematic review and meta-analysis. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association. 2010;8(3):235–44; quiz e32.
Stewart BW, Wild CP, editors. World cancer report 2014. International Agency for Research on Cancer: Lyon, France; 2014.
Terry PD, Rohan TE. Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for cancer research, cosponsored by the American society of preventive oncology. 2002;11(10 Pt 1):953–71.
Verhoeven RH, Karim-Kos HE, Coebergh JW, Brink M, Horenblas S, De Wit R, et al. Markedly increased incidence and improved survival of testicular cancer in the Netherlands. Acta Oncol. 2014;53(3):342–50.CrossRefPubMed
Van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12(6):575–82.CrossRefPubMed
Van Leersum NJ, Janssen-Heijnen ML, Wouters MW, Rutten HJ, Coebergh JW, Tollenaar RA, et al. Increasing prevalence of comorbidity in patients with colorectal cancer in the south of the Netherlands 1995-2010. International Journal of Cancer Journal International du Cancer. 2013;132(9):2157–63.CrossRefPubMed
Wever EM, Heijnsdijk EA, Draisma G, Bangma CH, Roobol MJ, Schroder FH, et al. Treatment of local-regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors. Br J Cancer. 2013;108(10):1971–7.PubMedPubMedCentralCrossRef
Witjes CD, Van den Akker SA, Visser O, Karim-Kos HE, De Vries E, Ijzermans JN, et al. Gallbladder cancer in the Netherlands: incidence, treatment and survival patterns since 1989. Digestive surgery. 2012;29(2):92–8.CrossRefPubMed
Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. J Am Med Assoc. 1950;143(4):329–36.CrossRefPubMed
Metagegevens
Titel
Epidemiologie van kanker
Auteurs
Prof. dr. V. E. P. P. Lemmens
Prof. dr. A. M. May
Copyright
2020
Uitgeverij
Bohn Stafleu van Loghum
Boek
Leerboek oncologie

Print ISBN: 978-90-368-2448-4

Elektronisch ISBN: 978-90-368-2449-1

Copyright: 2020

DOI
https://doi.org/10.1007/978-90-368-2449-1_3